Biotech Executive | CEO | COO | M&A & Fundraising | Oncology & Cell Therapy Innovator | Driving $B-Scale Exits
We are proud to share that our Scientific Founder, Professor Shimon Sakaguchi, has published new research in Nature that deepens our collective understanding of regulatory T-cell biology. We are fortunate to have Professor Shimon Sakaguchi actively engaged in RegCell’s scientific advancement. He provides privileged insights into Treg biology that are essential to the development and further evolution of our innovative approach to epigenetically reprogram pathogenic T-cells into lineage-stable, highly functional, antigen-specific Tregs to restore immune tolerance in patients with autoimmune diseases. https://lnkd.in/gA28S7jX #Tregs #Immunology #Autoimmunity #CellTherapy #Nature #FOXP3 #ImmuneTolerance #RegCell
Co-Founder & COO at xCARE, Inc. Former biotech CEO with a background in global pharma development. Passionate about driving cross-border innovation, talent mobility, and global project management.
2wGood luck to you Mike-san!